Report Detail
Global C-X-C Chemokine Receptor Type 4 Market Insights, Forecast to 2025
- RnM3028342 |
- 26 February, 2019 |
- Global |
- 124 Pages |
- QYResearch |
- Pharma & Healthcare
The global C-X-C Chemokine Receptor Type 4 market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the C-X-C Chemokine Receptor Type 4 market based on company, product type, end user and key regions.
This report studies the global market size of C-X-C Chemokine Receptor Type 4 in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of C-X-C Chemokine Receptor Type 4 in these regions.
This research report categorizes the global C-X-C Chemokine Receptor Type 4 market by top players/brands, region, type and end user. This report also studies the global C-X-C Chemokine Receptor Type 4 market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
AdAlta Pty Ltd.
Ambrx, Inc.
Anchor Therapeutics, Inc.
Biokine Therapeutics Ltd.
BioLineRx, Ltd.
Bristol-Myers Squibb Company
Eli Lilly and Company
Globavir Biosciences, Inc.
GlycoMimetics, Inc.
NeED Pharma s.r.l.
Pharis Biotec GmbH
Polyphor Ltd.
Sanofi
TaiGen Biotechnology Co., Ltd.
Upsher-Smith Laboratories, Inc.
X4 Pharmaceuticals, Inc.
Market size by Product
AM-3114
BL-8040
GMI-1359
HPH-112
Others
Market size by End User
Liver Cancer
Myocardial Infarction
Renal Cell Carcinoma
Stroke
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global C-X-C Chemokine Receptor Type 4 market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of C-X-C Chemokine Receptor Type 4 market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global C-X-C Chemokine Receptor Type 4 companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of C-X-C Chemokine Receptor Type 4 submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of C-X-C Chemokine Receptor Type 4 are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of C-X-C Chemokine Receptor Type 4 market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 C-X-C Chemokine Receptor Type 4 Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global C-X-C Chemokine Receptor Type 4 Market Size Growth Rate by Product
- 1.4.2 AM-3114
- 1.4.3 BL-8040
- 1.4.4 GMI-1359
- 1.4.5 HPH-112
- 1.4.6 Others
- 1.5 Market by End User
- 1.5.1 Global C-X-C Chemokine Receptor Type 4 Market Size Growth Rate by End User
- 1.5.2 Liver Cancer
- 1.5.3 Myocardial Infarction
- 1.5.4 Renal Cell Carcinoma
- 1.5.5 Stroke
- 1.5.6 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global C-X-C Chemokine Receptor Type 4 Market Size
- 2.1.1 Global C-X-C Chemokine Receptor Type 4 Revenue 2014-2025
- 2.1.2 Global C-X-C Chemokine Receptor Type 4 Sales 2014-2025
- 2.2 C-X-C Chemokine Receptor Type 4 Growth Rate by Regions
- 2.2.1 Global C-X-C Chemokine Receptor Type 4 Sales by Regions
- 2.2.2 Global C-X-C Chemokine Receptor Type 4 Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 C-X-C Chemokine Receptor Type 4 Sales by Manufacturers
- 3.1.1 C-X-C Chemokine Receptor Type 4 Sales by Manufacturers
- 3.1.2 C-X-C Chemokine Receptor Type 4 Sales Market Share by Manufacturers
- 3.1.3 Global C-X-C Chemokine Receptor Type 4 Market Concentration Ratio (CR5 and HHI)
- 3.2 C-X-C Chemokine Receptor Type 4 Revenue by Manufacturers
- 3.2.1 C-X-C Chemokine Receptor Type 4 Revenue by Manufacturers (2014-2019)
- 3.2.2 C-X-C Chemokine Receptor Type 4 Revenue Share by Manufacturers (2014-2019)
- 3.3 C-X-C Chemokine Receptor Type 4 Price by Manufacturers
- 3.4 C-X-C Chemokine Receptor Type 4 Manufacturing Base Distribution, Product Types
- 3.4.1 C-X-C Chemokine Receptor Type 4 Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers C-X-C Chemokine Receptor Type 4 Product Type
- 3.4.3 Date of International Manufacturers Enter into C-X-C Chemokine Receptor Type 4 Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global C-X-C Chemokine Receptor Type 4 Sales by Product
- 4.2 Global C-X-C Chemokine Receptor Type 4 Revenue by Product
- 4.3 C-X-C Chemokine Receptor Type 4 Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global C-X-C Chemokine Receptor Type 4 Breakdown Data by End User
6 North America
- 6.1 North America C-X-C Chemokine Receptor Type 4 by Countries
- 6.1.1 North America C-X-C Chemokine Receptor Type 4 Sales by Countries
- 6.1.2 North America C-X-C Chemokine Receptor Type 4 Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America C-X-C Chemokine Receptor Type 4 by Product
- 6.3 North America C-X-C Chemokine Receptor Type 4 by End User
7 Europe
- 7.1 Europe C-X-C Chemokine Receptor Type 4 by Countries
- 7.1.1 Europe C-X-C Chemokine Receptor Type 4 Sales by Countries
- 7.1.2 Europe C-X-C Chemokine Receptor Type 4 Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe C-X-C Chemokine Receptor Type 4 by Product
- 7.3 Europe C-X-C Chemokine Receptor Type 4 by End User
8 Asia Pacific
- 8.1 Asia Pacific C-X-C Chemokine Receptor Type 4 by Countries
- 8.1.1 Asia Pacific C-X-C Chemokine Receptor Type 4 Sales by Countries
- 8.1.2 Asia Pacific C-X-C Chemokine Receptor Type 4 Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific C-X-C Chemokine Receptor Type 4 by Product
- 8.3 Asia Pacific C-X-C Chemokine Receptor Type 4 by End User
9 Central & South America
- 9.1 Central & South America C-X-C Chemokine Receptor Type 4 by Countries
- 9.1.1 Central & South America C-X-C Chemokine Receptor Type 4 Sales by Countries
- 9.1.2 Central & South America C-X-C Chemokine Receptor Type 4 Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America C-X-C Chemokine Receptor Type 4 by Product
- 9.3 Central & South America C-X-C Chemokine Receptor Type 4 by End User
10 Middle East and Africa
- 10.1 Middle East and Africa C-X-C Chemokine Receptor Type 4 by Countries
- 10.1.1 Middle East and Africa C-X-C Chemokine Receptor Type 4 Sales by Countries
- 10.1.2 Middle East and Africa C-X-C Chemokine Receptor Type 4 Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa C-X-C Chemokine Receptor Type 4 by Product
- 10.3 Middle East and Africa C-X-C Chemokine Receptor Type 4 by End User
11 Company Profiles
- 11.1 AdAlta Pty Ltd.
- 11.1.1 AdAlta Pty Ltd. Company Details
- 11.1.2 Company Business Overview
- 11.1.3 AdAlta Pty Ltd. C-X-C Chemokine Receptor Type 4 Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 AdAlta Pty Ltd. C-X-C Chemokine Receptor Type 4 Products Offered
- 11.1.5 AdAlta Pty Ltd. Recent Development
- 11.2 Ambrx, Inc.
- 11.2.1 Ambrx, Inc. Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Ambrx, Inc. C-X-C Chemokine Receptor Type 4 Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Ambrx, Inc. C-X-C Chemokine Receptor Type 4 Products Offered
- 11.2.5 Ambrx, Inc. Recent Development
- 11.3 Anchor Therapeutics, Inc.
- 11.3.1 Anchor Therapeutics, Inc. Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Anchor Therapeutics, Inc. C-X-C Chemokine Receptor Type 4 Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Anchor Therapeutics, Inc. C-X-C Chemokine Receptor Type 4 Products Offered
- 11.3.5 Anchor Therapeutics, Inc. Recent Development
- 11.4 Biokine Therapeutics Ltd.
- 11.4.1 Biokine Therapeutics Ltd. Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Biokine Therapeutics Ltd. C-X-C Chemokine Receptor Type 4 Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Biokine Therapeutics Ltd. C-X-C Chemokine Receptor Type 4 Products Offered
- 11.4.5 Biokine Therapeutics Ltd. Recent Development
- 11.5 BioLineRx, Ltd.
- 11.5.1 BioLineRx, Ltd. Company Details
- 11.5.2 Company Business Overview
- 11.5.3 BioLineRx, Ltd. C-X-C Chemokine Receptor Type 4 Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 BioLineRx, Ltd. C-X-C Chemokine Receptor Type 4 Products Offered
- 11.5.5 BioLineRx, Ltd. Recent Development
- 11.6 Bristol-Myers Squibb Company
- 11.6.1 Bristol-Myers Squibb Company Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Bristol-Myers Squibb Company C-X-C Chemokine Receptor Type 4 Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Bristol-Myers Squibb Company C-X-C Chemokine Receptor Type 4 Products Offered
- 11.6.5 Bristol-Myers Squibb Company Recent Development
- 11.7 Eli Lilly and Company
- 11.7.1 Eli Lilly and Company Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Eli Lilly and Company C-X-C Chemokine Receptor Type 4 Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Eli Lilly and Company C-X-C Chemokine Receptor Type 4 Products Offered
- 11.7.5 Eli Lilly and Company Recent Development
- 11.8 Globavir Biosciences, Inc.
- 11.8.1 Globavir Biosciences, Inc. Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Globavir Biosciences, Inc. C-X-C Chemokine Receptor Type 4 Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Globavir Biosciences, Inc. C-X-C Chemokine Receptor Type 4 Products Offered
- 11.8.5 Globavir Biosciences, Inc. Recent Development
- 11.9 GlycoMimetics, Inc.
- 11.9.1 GlycoMimetics, Inc. Company Details
- 11.9.2 Company Business Overview
- 11.9.3 GlycoMimetics, Inc. C-X-C Chemokine Receptor Type 4 Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 GlycoMimetics, Inc. C-X-C Chemokine Receptor Type 4 Products Offered
- 11.9.5 GlycoMimetics, Inc. Recent Development
- 11.10 NeED Pharma s.r.l.
- 11.10.1 NeED Pharma s.r.l. Company Details
- 11.10.2 Company Business Overview
- 11.10.3 NeED Pharma s.r.l. C-X-C Chemokine Receptor Type 4 Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 NeED Pharma s.r.l. C-X-C Chemokine Receptor Type 4 Products Offered
- 11.10.5 NeED Pharma s.r.l. Recent Development
- 11.11 Pharis Biotec GmbH
- 11.12 Polyphor Ltd.
- 11.13 Sanofi
- 11.14 TaiGen Biotechnology Co., Ltd.
- 11.15 Upsher-Smith Laboratories, Inc.
- 11.16 X4 Pharmaceuticals, Inc.
12 Future Forecast
- 12.1 C-X-C Chemokine Receptor Type 4 Market Forecast by Regions
- 12.1.1 Global C-X-C Chemokine Receptor Type 4 Sales Forecast by Regions 2019-2025
- 12.1.2 Global C-X-C Chemokine Receptor Type 4 Revenue Forecast by Regions 2019-2025
- 12.2 C-X-C Chemokine Receptor Type 4 Market Forecast by Product
- 12.2.1 Global C-X-C Chemokine Receptor Type 4 Sales Forecast by Product 2019-2025
- 12.2.2 Global C-X-C Chemokine Receptor Type 4 Revenue Forecast by Product 2019-2025
- 12.3 C-X-C Chemokine Receptor Type 4 Market Forecast by End User
- 12.4 North America C-X-C Chemokine Receptor Type 4 Forecast
- 12.5 Europe C-X-C Chemokine Receptor Type 4 Forecast
- 12.6 Asia Pacific C-X-C Chemokine Receptor Type 4 Forecast
- 12.7 Central & South America C-X-C Chemokine Receptor Type 4 Forecast
- 12.8 Middle East and Africa C-X-C Chemokine Receptor Type 4 Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 C-X-C Chemokine Receptor Type 4 Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on C-X-C Chemokine Receptor Type 4 . Industry analysis & Market Report on C-X-C Chemokine Receptor Type 4 is a syndicated market report, published as Global C-X-C Chemokine Receptor Type 4 Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of C-X-C Chemokine Receptor Type 4 market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
